VelosBio

BiotechnologySeries BSan Diego, USvelosbio.com

Latest round

Series B

Last raised

Jul 2020

Total raised

$204M

Investors

18

About VelosBio

Founded in 2017 and based in California, US, VelosBio, Inc. operates as a biotechnology company that develops antibody-drug conjugates (ADCs) to treat patients with cancer such as hematological cancers and solid tumors.

Who invested in VelosBio

18 investors across 4 rounds

See all investors in VelosBio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 7, 2020

    Amount

    $137M

    Investors

    Locked

  2. Series A

    May 8, 2020

    Amount

    $24M

    Investors

    Locked

  3. Series A

    Sep 28, 2018

    Amount

    $35M

    Investors

    Locked

  4. Seed

    Feb 9, 2018

    Amount

    $7.7M

    Investors

    Locked

Questions about VelosBio

Who invested in VelosBio?

VelosBio has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has VelosBio raised?

VelosBio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did VelosBio last raise money?

VelosBio's most recent round on record is a Series B, in Jul 2020.

What does VelosBio do?

Founded in 2017 and based in California, US, VelosBio, Inc.

Where is VelosBio headquartered?

VelosBio is headquartered in San Diego, US.

Which VCs invest in companies like VelosBio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VelosBio's stage. Their profiles are linked below.

Raising like VelosBio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.